Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women (Q38464557)

3 September 2017

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

3 September 2017

1 reference

1 reference

1 reference

Seong-Su Moon

1

1 reference

PubMed ID

22407492

3 September 2017

Young-Sil Lee

series ordinal

2

1 reference

PubMed ID

22407492

3 September 2017

Sung Woo Kim

series ordinal

3

1 reference

3 September 2017

11 March 2012

1 reference

3 September 2017

1 reference

3 September 2017

42

1 reference

3 September 2017

2

1 reference

3 September 2017

423-429

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9639-6

3 September 2017

0 references

cites work

Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

The relationship between low bone mass and metabolic syndrome in Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Epidemiology, trends, and morbidities of obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Retinoid x receptor heterodimers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Nonalcoholic fatty liver disease: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Nonalcoholic fatty liver disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Relationship of obesity with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Osteoporosis and skeletal fractures in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Osteoporosis in primary biliary cirrhosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

New understanding and treatments for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9639-6

Prevalence of and risk factors for hepatic steatosis in Northern Italy

21 January 2018

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver

1 reference

12 December 2020

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

12 December 2020

Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women

1 reference

12 December 2020

Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Population-based study of survival after osteoporotic fractures

1 reference

12 December 2020

Influence of diabetes mellitus on vertebral fractures in men with acromegaly

1 reference

12 December 2020

Non-invasive assessment of bone density in primary biliary cirrhosis.

1 reference

12 December 2020

Adipose tissue in obesity--an inflammatory issue

1 reference

12 December 2020

Role of RANKL and RANK in bone loss and arthritis.

1 reference

12 December 2020

Diagnosis of fatty liver disease: is biopsy necessary?

1 reference

12 December 2020

Signalling role of adipose tissue: adipokines and inflammation in obesity

1 reference

12 December 2020

10.1007/S12020-012-9639-6

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

22407492